# US 2017/0253910 A1 · Methods for delivering an analyte to transmembrane pores

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2017/0253910 A1
- Document ID: US20170253910A1
- Status: Published application
- Kind: A1
- Application number: 15/519,606
- Filed: 2015-10-06
- Published: 2017-09-07
- Earliest claimed: 2014-10-17
- Assignees: Oxford Nanopore Technologies PLC
- Applicants: Oxford Nanopore Technologies Ltd.
- Inventors: Clive Gavin Brown; Daniel Ryan Garalde; Andrew John Heron; Daniel John Turner; James White
- Web page: https://patentgrep.com/patent/US20170253910A1

## CPC

- C12Q 1/6804: Nucleic acid analysis using immunogens (immunoassay G01N33/53)
- C12N 9/52: derived from bacteria {or Archaea}
- C12N 15/1013: {by using magnetic beads}
- C12Q 1/6869: Methods for sequencing
- G01N 33/48721: {Investigating individual macromolecules, e.g. by translocation through nanopores (Coulter counters in general G01N15/12; fabrication methods for nanoscale apertures B81B1/00; sequencing of nucleic acids C12Q1/68)}
- G01N 33/48728: {Investigating individual cells, e.g. by patch clamp, voltage clamp (investigating individual particles in general G01N15/10)}
- G01N 33/6872: {Intracellular protein regulatory factors and their receptors, e.g. including ion channels}
- B03C 2201/18: Magnetic separation whereby the particles are suspended in a liquid
- C12Q 2523/303: Applying a physical force on a nucleic acid
- C12Q 2525/197: incorporating a spacer/coupling moiety
- C12Q 2563/149: Particles, e.g. beads
- C12Q 2563/155: Particles of a defined size, e.g. nanoparticles
- C12Q 2565/631: being a biochannel or pore
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- B03C: MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS (separating isotopes B01D59/00; combinations of magnetic or electrostatic separation with separation of solids by other means B03B, B07B)

## Abstract

The invention relates to a new method of delivering an analyte to a transmembrane pore in a membrane. The method involves the use of microparticles.

## Claims

### Claim 1

A method for delivering an analyte to a transmembrane pore in a membrane, comprising:
(a) providing the analyte attached to a microparticle; and
(b) delivering the microparticle towards the membrane and thereby delivering the analyte to the transmembrane pore.

### Claim 2 (depends on 1)

A method according to claim 1, wherein the method is for delivering an increased concentration of an analyte to a transmembrane pore in a membrane.

### Claim 3 (depends on 1)

A method according to claim 1, wherein the method is an improved method of characterising an analyte using a transmembrane pore in a membrane by delivering an increased concentration of the analyte to the transmembrane pore.

### Claim 4 (depends on 2)

A method according to claim 2, wherein the concentration of the analyte delivered to the transmembrane pore is preferably increased by at least about 10 fold.

### Claim 5 (depends on 1)

A method according to claim 1, wherein step (b) comprises positioning the microparticle near to or adjacent to the membrane and allowing the microparticle to move towards the membrane.

### Claim 6 (depends on 1)

A method according to claim 1, wherein the method comprises (a) allowing the microparticle to move along an electrochemical gradient, diffusion gradient, hydrophilic gradient or hydrophobic gradient (b) allowing the microparticle to move within a magnetic field; (c) allowing the microparticle to move within an electrical field; (d) allowing the microparticle to move under pressure; or (e) allowing the microparticle to move with gravity.

### Claim 7 (depends on 1)

A method according to claim 1, wherein the analyte is transiently attached to the microparticle.

### Claim 8 (depends on 1)

A method according to claim 1, wherein 2 or more, 3 or more, 4 or more, 5 or more, 6 or more, 7 or more, 8 or more, 9 or more, 10 or more, 20 or more, 30 or more, 50 or more, 100 or more, 500 or more, 1,000 or more, 5,000 or more, 10,000 or more, 100,000 or more, 1000,000 or more or 5000,000 or more analytes are attached to the microparticle.

### Claim 9 (depends on 1)

A method according to claim 1, wherein the analyte comprises one or more anchors which are capable of coupling to the membrane.

### Claim 10 (depends on 9)

A method according to claim 9, wherein the method further comprises coupling the analyte to the membrane using the one or more anchors.

### Claim 11 (depends on 9)

A method according to claim 9, wherein the one or more anchors comprise a polypeptide anchor and/or a hydrophobic anchor.

### Claim 12 (depends on 11)

A method according to claim 11, wherein the hydrophobic anchor comprises a lipid, fatty acid, sterol, carbon nanotube or amino acid.

### Claim 13 (depends on 9)

A method according to claim 9, wherein the one or more anchors comprise a linker.

### Claim 14 (depends on 9)

A method according to claim 9, wherein the analyte is coupled transiently to the membrane.

### Claim 15 (depends on 7)

A method according to claim 7, wherein the analyte is attached to the microparticle via hybridisation.

### Claim 16 (depends on 1)

A method according to claim 1, wherein the membrane is an amphiphilic layer or a solid state layer.

### Claim 17 (depends on 1)

A method according to claim 1, wherein the microparticle is formed from a ceramic, glass, silica, a polymer or a metal.

### Claim 18 (depends on 1)

A method according to claim 1, wherein the microparticle is 500 μm in diameter or less.

### Claim 19 (depends on 1)

A method according to claim 1, wherein the microparticle is magnetic.

### Claim 20 (depends on 1)

A method according to claim 1, wherein the transmembrane pore is a transmembrane protein pore.

### Claim 21 (depends on 20)

A method according to claim 20, wherein the transmembrane protein pore is derived from Mycobacterium smegmatis porin (Msp), α-hemolysin (α-HL) or lysenin.

### Claim 22 (depends on 1)

A method according to claim 1, wherein the analyte is a polymer.

### Claim 23 (depends on 1)

A method according to claim 1, wherein the analyte is a polynucleotide.

### Claim 24 (depends on 23)

A method according to claim 23, wherein the method is for delivering an increased concentration of a polynucleotide to a transmembrane pore in a membrane.

### Claim 25 (depends on 22)

A method according to claim 22, wherein the method is an improved method of characterising or sequencing a polynucleotide using a transmembrane pore in a membrane by delivering an increased concentration of the polynucleotide to the transmembrane pore.

### Claim 26 (depends on 23)

A method for characterising a polynucleotide, comprising (a) carrying out a method according to claim 23; (b) allowing the polynucleotide to interact with the transmembrane pore such that the polynucleotide moves through the pore; and (c) taking one or more measurements as the polynucleotide moves with respect to the pore, wherein the measurements are indicative of one or more characteristics of the polynucleotide, and thereby characterising the polynucleotide.

### Claim 27 (depends on 26)

A method according to claim 26, wherein the one or more characteristics are selected from (i) the length of the polynucleotide, (ii) the identity of the polynucleotide, (iii) the sequence of the polynucleotide, (iv) the secondary structure of the polynucleotide and (v) whether or not the polynucleotide is modified.

### Claim 28 (depends on 26)

A method according to claim 26, wherein the one or more characteristics of the polynucleotide are measured by electrical measurement and/or optical measurement.

### Claim 29 (depends on 28)

A method according to claim 28, wherein the electrical measurement is a current measurement, an impedance measurement, a tunnelling measurement or a field effect transistor (FET) measurement.

### Claim 30 (depends on 26)

A method according to claim 26, wherein step b) further comprises using a polynucleotide binding protein to control the movement of the polynucleotide through the pore.

### Claim 31 (depends on 30)

A method according to claim 30, wherein the method comprises:
b) allowing the polynucleotide to interact with the pore and the polynucleotide binding protein such that the polynucleotide moves through the pore and the protein controls the movement of the polynucleotide through the pore; and
c) measuring the current passing through the pore as the polynucleotide moves with respect to the pore wherein the current is indicative of one or more characteristics of the polynucleotide and thereby characterising the polynucleotide.

### Claim 32 (depends on 31)

A method according to claim 31, wherein the polynucleotide binding protein is derived from a helicase.

### Claim 33 (depends on 1)

A method according to claim 1, wherein the method further comprises removing the microparticle from the membrane.

### Claim 34 (depends on 33)

A method according to claim 33, wherein the method further comprises removing the microparticle from the membrane using a magnetic field or a flow-based method.

### Claim 35 (depends on 33)

A method according to claim 33, wherein the method comprises:
(a) providing a first analyte in a first sample attached to a first microparticle;
(b) delivering the first microparticle towards the membrane and thereby delivering the first analyte to the transmembrane pore;
(c) removing the first microparticle from the membrane;
(d) providing a second analyte in a second sample attached to a second microparticle;
(e) delivering the second microparticle towards the membrane and thereby delivering the second analyte to the transmembrane pore.

### Claim 36 (depends on 35)

A method according to claim 35, wherein the method further comprises (i) between steps (b) and (c) allowing the first analyte to interact with the transmembrane pore and taking one or more measurements during the interaction, wherein the measurements are indicative of the presence, absence or one or more characteristics of the first analyte and/or (ii) after step (e) allowing the second analyte to interact with the transmembrane pore and taking one or more measurements during the interaction, wherein the measurements are indicative of the presence, absence or one or more characteristics of the second analyte.

### Claim 37 (depends on 35)

A method according to claim 35, wherein the first and second analytes are polynucleotides and the method further comprises (i) between steps (b) and (c) allowing the first polynucleotide to interact with the transmembrane pore such that the first polynucleotide moves through the pore and taking one or more measurements as the first polynucleotide moves with respect to the pore, wherein the measurements are indicative of one or more characteristics of the first polynucleotide, and thereby characterising the first polynucleotide and/or (ii) after step (e) allowing the second polynucleotide to interact with the transmembrane pore such that the second polynucleotide moves through the pore and taking one or more measurements as the second polynucleotide moves with respect to the pore, wherein the measurements are indicative of one or more characteristics of the second polynucleotide, and thereby characterising the second polynucleotide.

### Claim 38 (depends on 35)

A method according to claim 35, wherein step (c) comprises removing the microparticle and the first analyte.

### Claim 39 (depends on 1)

A method for determining the presence, absence or one or more characteristics of an analyte using a transmembrane pore, comprising (a) carrying out a method according to claim 1; (b) allowing the analyte to interact with the transmembrane pore; and (c) taking one or more measurements during the interaction, wherein the measurements are indicative of the presence, absence or one or more characteristics of the analyte.

### Claim 40

A kit for delivering an analyte to a transmembrane pore in a membrane, comprising (a) a microparticle and (b) one or more anchors which are capable of coupling the analyte to the membrane.
